Sony (TYO:6758) will reportedly sell its 5% stake in Olympus (TYO:7733) back to the company for nearly $760 million. The deal for Sony’s 68.9-million-share stake is worth ¥80.4 billion, or about $756.7 million, Reuters reported. Hedge fund Third Point, run by activist investor Daniel Loeb, had called for Sony to divest its Olympus shares, although a Sony […]
Olympus (TYO:7733) said today it launched its Orbeye 4K-3D video microscope developed by Sony Olympus Medical solutions, a joint venture between Olympus and Sony‘s (TYO:6758) Imaging Products & Solutions biz. The company said the Orbeye microscope is designed to provide high-resolution 3D imaging of the structure of tissue, blood vessels and other features to enable more accurate […]
M3 Inc., a Sony (TYO:6758)-backed Japanese web portal for physicians, is getting into the medical device game with an investment in MedTecHeart and its outside-the-body cardiac assist device. A joint venture between Tokyo Medical & Dental University and the Tokyo Institute of Technology, MedTecHeart’s extracorporeal ventricular assist device is designed to treat patients with heart failure using […]
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking outside investors to buy a stake in the healthcare business amid laying off nearly 7,000 workers, wants to focus on its core nuclear energy and chip businesses. Private equity shops KKR and Bain […]
(Reuters) — Sony Corp. (TYO:6758) and Olympus (TYO:7733) said they plan to unveil an ultra high-definition surgical endoscope this week, the 1st major product from a joint venture formed 3 years ago. The product allows physicians to view clearer, more instant images of internal organs, aiding precision during surgical procedures, the medical device makers told Reuters ahead of an […]
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.